NeuroOne Q3 Revenue Up 16% to $2.0M, Gross Margin Hits 59.9%; Cash Drops to $2.0M

summarizeSummary

NeuroOne's Q3 FY2026 revenue grew 16% to $2.0M with record 59.9% gross margins, but cash fell to $2.0M and the company raised $1.4M via ATM. Lead investor increased stake to 12.5%.

check_boxKey Events · Earnings and Guidance · NMTC

• Q3 Revenue Up 16% to $2.0M

  Product revenue increased 16% year-over-year to $2.0 million, driven by higher OneRF product sales. Product gross margin expanded to a record 59.9% from 53.9%.

• FY2026 Orders of $11.2M

  The company has received $11.2 million in product orders for fiscal 2026 and expects recognized revenue of $9.2–$10.5 million, with $1.7 million in backlog as of June 30, 2026.

• Cash Drops to $2.0M

  Cash and cash equivalents fell to $2.0 million as of June 30, 2026, from $6.6 million at September 30, 2025. The company raised $0.4 million via ATM during Q3 and an additional $1.0 million on July 13, 2026.

• Lead Investor Ups Stake to 12.5%

  Subsequent to quarter end, the lead investor increased ownership of NeuroOne's outstanding common stock from 7.4% to 12.5%.

auto_awesomeAnalysis · NMTC · Industrial Applications And Services

Fiscal Q3 2026 results show product revenue up 16% year-over-year to $2.0 million and record gross margins of 59.9%. The company holds $11.2 million in FY2026 product orders and expects recognized revenue of $9.2–$10.5 million, yet cash has fallen to $2.0 million from $6.6 million at fiscal year start, and the company continues to rely on its ATM program, raising $1.4 million in the quarter and subsequent period. The lead investor increased its stake from 7.4% to 12.5%, a notable vote of confidence. The ISO 13485 certification and StereoCED platform progress are positive, but the cash position and ongoing dilution remain key risks.